Vidya Sankar

Etanercept in Sjögren's syndrome: A twelve‐week randomized, double‐blind, placebo‐controlled pilot clinical trial

Vidya Sankar, Michael T. Brennan, Marc R. Kok et al. · Arthritis & Rheumatism · 2004 · 305 citations

Medicine, Pharmacology, Pharmacotherapy +15

The role of histopathological characteristics in distinguishing amalgam‐associated oral lichenoid reactions and oral lichen planus

Martin H. Thornhill, Vidya Sankar, Xiaojun Xu et al. · Journal of Oral Pathology and Medicine · 2006 · 123 citations · Full text

Dentistry, Oral Medicine, Oral Pathology +15

Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation

Niki M. Moutsopoulos, G E Katsifis, Nikola Angelov et al. · Annals of the Rheumatic Diseases · 2008 · 76 citations

Life Sciences, Immunology, Pharmacotherapy +17

Serum lipid levels in Sjogren's syndrome

Beatrijs M. Lodde, Vidya Sankar, Marc R. Kok et al. · Lara D. Veeken · 2005 · 72 citations

Medicine, Immunology, Internal Medicine +14

Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome

Stanley R. Pillemer, Michael T. Brennan, Vidya Sankar et al. · Arthritis Care & Research · 2004 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +15